Oral Graft-Versus-Host Disease - 21/03/14
![](/templates/common/images/mail.png)
Résumé |
Allogeneic hematopoietic cell transplantation (allo-HCT) is used for the treatment of a variety of disorders, primarily hematologic malignancies. Graft-versus-host disease (GVHD) is a significant complication following allo-HCT and a major cause of morbidity and mortality. The oral cavity is frequently involved in GVHD, leading to pain, functional impairment, and reduced quality of life. Early diagnosis, management, and long-term follow-up of oral GVHD are important components of overall patient care.
Le texte complet de cet article est disponible en PDF.Keywords : Graft-versus-host disease, GVHD, Allogeneic, Hematopoietic cell transplantation, Oral mucosal disease
Plan
Disclosure: None. |
Vol 58 - N° 2
P. 351-368 - avril 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?